DBD vs DOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

DBD

45.7
AI Score
VS
DBD Wins

DOV

38.4
AI Score

Investment Advisor Scores

DBD

46score
Recommendation
HOLD

DOV

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric DBD DOV Winner
Forward P/E 12.1655 17.1233 DBD
PEG Ratio 0 1.4882 Tie
Revenue Growth 1.7% 6.9% DOV
Earnings Growth 34.2% 14.1% DBD
Tradestie Score 45.7/100 38.4/100 DBD
Profit Margin 2.9% 13.5% DOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL DBD

Relative Price Performance (Last 90 Days)

DBD 1M: -8.6% · 3M: -19.6% DOV 1M: -9.1% · 3M: -13.5%

Current Technical Phase

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.1%), weak momentum, RSI 35

RSI (14): 34.5 · Price: $65.62

DOV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 35

RSI (14): 35.5 · Price: $189.05

Fundamentals Snapshot

Metric DBD DOV
Market Cap
Forward P/E 9.4 16.2
Trailing P/E 22.1 23.2
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.4%
Operating Margin 0.1% 0.2%
EPS 2.96 8.09
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.